home / stock / pepg / pepg news


PEPG News and Press, PepGen Inc.

Stock Information

Company Name: PepGen Inc.
Stock Symbol: PEPG
Market: NASDAQ
Website: pepgen.com

Menu

PEPG PEPG Quote PEPG Short PEPG News PEPG Articles PEPG Message Board
Get PEPG Alerts

News, Short Squeeze, Breakout and More Instantly...

PEPG - PepGen: Stock Slides On FDA Study Hold - I'm Firmly On The Sidelines

2026-03-05 14:49:43 ET Investment Overview The stock of PepGen Inc. ( PEPG ) is down >20% in early trading today, after the company released its Q4 and full-year 2025 earnings, and shared the news that the FDA had placed a partial clinical hold on its FREEDOM2-DM1...

PEPG - PepGen slides on FDA partial hold on mid-stage trial for lead asset

2026-03-05 06:57:50 ET More on PepGen Seeking Alpha’s Quant Rating on PepGen Historical earnings data for PepGen Financial information for PepGen Read the full article on Seeking Alpha For further details see: PepGen slides on FDA partial h...

PEPG - PepGen GAAP EPS of -$0.27 beats by $0.12

2026-03-05 04:23:24 ET More on PepGen Seeking Alpha’s Quant Rating on PepGen Historical earnings data for PepGen Financial information for PepGen Read the full article on Seeking Alpha For further details see: PepGen GAAP EPS of -$0.27 beat...

PEPG - PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

– FREEDOM2-DM1 5 mg/kg cohort data expected in Q1 2026 – – Patient dosing in the FREEDOM2 10 mg/kg cohort is proceeding in Canada and the UK, with data expected in 2H 2026 – – FREEDOM2 trial open in South Korea, Australia, and New Zealand –...

PEPG - PepGen Announces Regulatory Updates on FREEDOM2

- U.S. FDA places FREEDOM2 trial on partial clinical hold related to preclinical pharmacology and toxicology - - Received regulatory clearance to initiate FREEDOM2 in South Korea, Australia, and New Zealand and dosing of the 10 mg/kg cohort continues in the UK and Canada - - PepGen reiter...

PEPG - PepGen to Participate in the Leerink Global Healthcare Conference

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that James McArthur, PhD, President and CEO of PepGen, will ...

PEPG - Expected US Company Earnings on Monday, March 2nd, 2026

Astrana Health Inc. (ASTH) is expected to report $0.15 for Q4 2025 Sealed Air Corporation (SEE) is expected to report $0.72 for Q4 2025 Surgery Partners Inc. (SGRY) is expected to report $0.27 for Q4 2025 Kuehne + Nagel International AG ADR (KHNGY) is expected to report $0.4 for Q4 20...

PEPG - Expected US Company Earnings on Monday, February 23rd, 2026

Controladora Vuela Compania de Aviacion S.A.B. de C.V. American Depositary Shares each representing ten (10) Ordinary Participation Certificates (VLRS) is expected to report $0.25 for Q4 2025 Galapagos NV (GLPG) is expected to report $1 for Q4 2025 Octave Specialty Group Inc. (OSG) is exp...

PEPG - PEPG - Historical Price Movements Surrounding Earnings

2026-02-22 17:38:53 ET PepGen Inc. (PEPG) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 11.01%. The average open to low on the day of earnings was -10.00%. The average open to close on...

PEPG - PEPG - Historical Earnings Price Analysis

2026-02-22 17:33:56 ET PepGen Inc. (PEPG) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in PEPG stock price following earnings has averaged ±6.50% , with a median of 0.81%. The sing...

Next 10